Halcinonide Topical
Halcinonide is a topical corticosteroid used to relieve inflammation, itching, and other skin symptoms caused by corticosteroid-responsive skin conditions.
🧬 Where this information comes from Click to expand
The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 7 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →
📖 Halcinonide Topical: Patient Information Guide
A plain-language walkthrough of Halcinonide Topical — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.
🎯What it's used for▾
Halcinonide topical is used to calm inflammation and itching in skin conditions that respond to corticosteroid treatment.
- Halog Solution (0.1%) is approved to relieve the inflammatory and itchy symptoms of corticosteroid-responsive skin conditions.
- Halog Cream is used for corticosteroid-responsive skin conditions, including psoriasis and other hard-to-treat conditions — sometimes using an occlusive dressing technique when prescribed.
⚙️How it works▾
Halcinonide is a corticosteroid that reduces inflammation, relieves itching, and constricts (narrows) blood vessels in the skin. These combined actions help calm redness, swelling, and discomfort in irritated skin. The exact inflammation-fighting mechanism isn't fully understood, but these effects work together to bring relief to inflamed skin conditions.
The amount absorbed into your body depends on the condition of your skin, the area treated, and whether an occlusive (airtight) dressing is used. Inflamed or damaged skin absorbs more of the medication. Once absorbed, it is processed by the liver and eliminated by the kidneys.
💊How it's taken▾
Halog Cream is typically applied to the affected skin two to three times daily, rubbed in gently. Halog Solution is applied topically as directed by your prescriber. Always follow your doctor's instructions and your product label — do not apply more than prescribed or cover treated areas with airtight dressings unless specifically told to do so.
- For Halog Cream with an occlusive dressing (psoriasis or resistant conditions): apply at night, cover with a nonporous film, and remove in the morning — then apply cream again without a dressing during the day.
- If you miss a dose, apply it as soon as you remember — but if it's nearly time for your next dose, skip the missed one and continue your regular schedule.
🤒Side effects — in detail▾
Most side effects from halcinonide happen at the skin where you apply it and are generally mild, though they can occur more often with occlusive dressings.
- Burning, stinging, or irritation
- Itching
- Skin dryness
- Folliculitis (inflamed hair follicles)
- Acne-like skin eruptions
- Skin thinning (atrophy) or stretch marks (striae) with long-term use
- Lighter skin patches (hypopigmentation)
- Secondary skin infection
- Excessive hair growth (hypertrichosis) at the application site
Contact your doctor right away if you notice signs of skin infection (warmth, oozing, increased pain) or if you develop body-wide symptoms that suggest systemic absorption of the medication.
⚠️Warnings & precautions▾
- Systemic absorption: This medication can be absorbed through the skin in amounts large enough to cause body-wide (systemic) effects — especially when used over large areas, for long periods, on inflamed skin, or under occlusive dressings. Use only as directed.
- Occlusive dressings and infection: If a skin infection develops while using an occlusive dressing, stop the dressing immediately and contact your doctor. Appropriate infection treatment will be needed.
- Skin changes: Long-term use can cause skin thinning, stretch marks, and color changes — use the smallest effective amount for the shortest time needed.
- Allergic reactions: Do not use if you are allergic to halcinonide or any ingredient in the product.
🔀What it interacts with▾
The FDA label for halcinonide topical does not list specific drug or food interactions. However, there are important cautions around how it is used:
- Occlusive dressings: Using airtight bandages or wraps over the treated area greatly increases how much medication is absorbed into your body — only use this technique if your doctor prescribes it.
- Inflamed or broken skin: Damaged skin absorbs significantly more medication, raising the risk of systemic effects.
This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.
📋Before taking it▾
- Tell your doctor if you have ever had an allergic reaction to any corticosteroid medication or any ingredient in a Halog product — this medication is contraindicated in those with such a history.
- Let your doctor know if you are pregnant or breastfeeding before using this medication.
- Discuss all other medications and skin products you are using with your prescriber.
- Use with extra caution if applying over large areas of skin or using occlusive dressings, as this increases systemic absorption.
🚑If you take too much▾
Using too much halcinonide topically — or applying it over large areas or under airtight dressings for extended periods — can allow enough medication to absorb into your body to cause systemic corticosteroid effects. If you think you or someone else may have absorbed too much, contact your doctor or a poison control center right away.
📡Pharmacodynamics — effects in the body▾
Halcinonide works at the skin level to reduce inflammation, relieve itching, and constrict blood vessels. These three actions together — anti-inflammatory, antipruritic (anti-itch), and vasoconstrictive — help calm the redness, swelling, and discomfort of inflamed skin conditions. Stronger vasoconstriction in lab testing generally correlates with greater effectiveness in practice.
🔬Pharmacokinetics — how your body processes it▾
How much halcinonide is absorbed through the skin depends on several factors: the type of product (vehicle), the condition of the skin barrier, the area being treated, and whether an occlusive dressing is used. Inflamed or damaged skin absorbs significantly more than healthy, intact skin, and occlusive dressings greatly increase absorption. Once it enters the bloodstream, it follows the same pathways as oral corticosteroids — it binds to proteins in the blood, is metabolized (broken down) primarily in the liver, and is then eliminated mainly through the kidneys, with some excretion via bile.
📦How to store it▾
Store at room temperature; avoid freezing and temperatures above 104° F.
📄 Written from Halcinonide Topical’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →
🩺 Pharmacist Counseling Corner
Quick, plain-English answers to the questions patients ask most about Halcinonide Topical — the kind of thing our pharmacy team would talk through with you at the counter.
What skin conditions does this medication actually treat? ▾
How often should I apply it, and do I rub it in? ▾
My doctor mentioned using an occlusive dressing — what does that mean and is it safe? ▾
What side effects should I expect, and when should I call my doctor? ▾
Can I use this on my face or around my eyes? ▾
Is it safe to use if I'm pregnant or breastfeeding? ▾
Is Halcinonide Topical available over the counter? ▾
When was Halcinonide Topical first available? ▾
Who makes Halcinonide Topical? ▾
💬 Answers drafted from Halcinonide Topical’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →
🧰 Keep exploring
💊 How Halcinonide Topical comes
Halcinonide Topical is available in 2 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.
Topical cream, ointment or gel
How this form is used
- Halog Cream is used to relieve inflammation and itching caused by corticosteroid-responsive skin conditions
- Halog Cream may be used with an occlusive dressing technique for psoriasis or other hard-to-treat skin conditions, as directed by a doctor
- Halog Cream is generally applied to the affected area two to three times daily — rub in gently
- Halog Cream occlusive dressing technique: rub a small amount into the lesion, reapply a thin coat, then cover with a nonporous film and seal the edges — only as prescribed
- Halog Cream can be applied in the evening under an occlusive dressing and removed in the morning (12-hour regimen), with additional cream applied without a dressing during the day
- If a skin infection develops while using Halog Cream under an occlusive dressing, stop the dressing and contact your doctor
Topical solution
How this form is used
- Halog Solution (0.1%) is used to relieve inflammation and itching caused by corticosteroid-responsive skin conditions
- Halog Solution is applied topically to the affected area as directed by your doctor — follow your prescriber's instructions and the product label
📊 Halcinonide Topical across the U.S. market
How Halcinonide Topical appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.
FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.
📈 How widely Halcinonide Topical is used
A general measure of how commonly Halcinonide Topical is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q2–Q4 2025, summed across every form and brand of the drug.
Think of this as a proxy for how widely Halcinonide Topical is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.
How commonly is Halcinonide Topical prescribed? Of the 1,596 medications we measure, Halcinonide Topical ranks #730 by Medicaid prescriptions — more than 54% of them.
Utilization by Halcinonide Topical product
Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.
halcinonide 1 MG/ML Topical Solution Most dispensed
Summed across the 1 of 4 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 310669
halcinonide 1 MG/ML Topical Cream
Summed across the 1 of 10 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 103467
Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.
Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Halcinonide Topical, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 2 of 14 listed Halcinonide Topical NDCs with Medicaid activity.
🔍 Compare Halcinonide Topical products
A representative set of FDA-listed product records for Halcinonide Topical — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)
| Strength | Route | Manufacturer / Labeler | Category ⓘ | Details |
|---|---|---|---|---|
| 💊Topical cream, ointment or gel | ||||
| 1 mg/g | Topical | Genus Lifesciences Inc. | NDA | View NDC → |
| 1 mg/g | Topical | Glasshouse Pharmaceuticals Limited Canada × 2 listings | ANDA | View NDC → |
| 1 mg/g | Topical | Mylan Pharmaceuticals Inc. | ANDA | View NDC → |
| 1 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | NDA | View NDC → |
| 1 mg/g | Topical | Sun Pharmaceutical Industries, Inc. × 2 listings | NDA AUTHORIZED GENERIC | View NDC → |
| 💊Topical solution | ||||
| 1 mg/mL | Topical | E.R. Squibb & Sons, L.L.C. | NDA | View NDC → |
| 1 mg/mL | Topical | Genus Lifesciences Inc. | NDA | View NDC → |
| 1 mg/mL | Topical | INA Pharmaceutics Inc | ANDA | View NDC → |
| 1 mg/mL | Topical | Sun Pharmaceutical Industries, Inc. | NDA | View NDC → |
Showing 12 of 12 products — FDA National Drug Code Directory. See every product, package size and price: browse all 12 Halcinonide Topical NDCs →
📈 What people report — real-world data (FDA FAERS)
After a medicine reaches the market, patients, doctors and drugmakers can send the FDA reports of problems they think may be linked to it. Here’s what’s been reported for Halcinonide Topical — a signal of what to watch for, not proof the drug caused it.
Source: openFDA, from the FDA Adverse Event Reporting System (FAERS). These are voluntary reports — they don’t prove the drug caused the effect, and counts reflect how often something was reported, not how often it actually happens. Reports also often name the very problem the medicine is taken for — a common reason to file one is that the drug didn’t help — so for a pain reliever you may see “pain” high on the list; that points to why the report was filed, not to the drug causing the symptom. This counts every report that lists Halcinonide Topical in any role, so the total runs higher than the FDA’s official dashboard, which counts only cases where the drug is the suspect. For the authoritative figures, see the FDA FAERS Public Dashboard. Always talk to your pharmacist or doctor.
🏛️ The road to your pharmacy
How Halcinonide Topical went from FDA review to the pharmacy shelf — the key milestones in its regulatory journey.
Source: Drugs@FDA.
🚨 Recall history
A recall is when a specific batch of a medicine is pulled from the market — usually a manufacturing issue, not a problem with the drug itself. Class I is most serious, Class III least.
Source: openFDA drug enforcement (recall) reports.
RxNorm Concept Web — From Ingredient to Every Form and Strength
This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.
RxCUI 5084 3 dose forms · 3 strengths
-
Dose form (SCDF) Topical Cream RxCUI 377707In current FDA listingsClinical drug / strength (SCD) 1 MG/MLRxCUI 103467 -
Dose form (SCDF) Topical Ointment RxCUI 372370In current FDA listingsClinical drug / strength (SCD) 0.001 MG/MGRxCUI 197750 -
Dose form (SCDF) Topical Solution RxCUI 372371In current FDA listingsClinical drug / strength (SCD) 1 MG/MLRxCUI 310669
Look up RxCUI 5084 in the RxCUI Atlas →
RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.
📦 Supply & shortage status
Whether Halcinonide Topical is in short supply in the U.S. right now, plus any shortage history the FDA has on record. A shortage usually reflects a manufacturing or demand issue — not a safety problem with the drug.
Source: openFDA, from the FDA Drug Shortages database.
🏷️ Sold under these brand names
🏭 Manufacturers & labelers
RxNorm drug class
Halcinonide Topical belongs to the Corticosteroid class.
Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.
🔬 Where this comes from
Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.
How we combine label and product data
HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 7 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.
Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Sun Pharmaceutical Industries, Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.
This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.